The Liver Cancer Therapeutics Market is predicted to reach US$ by 2030 from US$ 1.8 billion in 2021, and to grow at a CAGR of 19.5% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
By Therapy Type (Chemotherapy, Immunotherapy, and Targeted Therapy), by Distribution Channel (Retail Pharmacy, Online Pharmacy, and Hospital Pharmacy
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Pfizer Inc., Bristol-Myers & Squibb Company, Exelixis Inc., Merck Sharp & Dohme Corp., Eli Lilly & Company, F. Hoffman-La Roche Ltd., Eisai Co., Ltd., Celgene Corporation, Amgen Inc., and Onyx Pharmaceuticals, Inc. among others
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Liver Cancer Therapeutics - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Liver Cancer Therapeutics - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Liver Cancer Therapeutics - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Liver Cancer Therapeutics - ANALYSIS & FORECAST, BY REGION
North America Liver Cancer Therapeutics
1. North America Liver Cancer Therapeutics , by Country
1. US
2. Canada
1. North America Liver Cancer Therapeutics , by Product
2. North America Liver Cancer Therapeutics , by Type
3. North America Liver Cancer Therapeutics , by Gender
4. North America Liver Cancer Therapeutics , by Sales Channel
3. Europe Liver Cancer Therapeutics
1. Europe Liver Cancer Therapeutics , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Liver Cancer Therapeutics , by Product
3. Europe Liver Cancer Therapeutics , by Type
4. Europe Liver Cancer Therapeutics , by Gender
5. Europe Liver Cancer Therapeutics , by Sales Channel
4. Asia Pacific Liver Cancer Therapeutics
1. Asia Pacific Liver Cancer Therapeutics , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Liver Cancer Therapeutics , by product
3. Asia Pacific Liver Cancer Therapeutics , by Type
4. Asia Pacific Liver Cancer Therapeutics , by Gender
5. Asia Pacific Liver Cancer Therapeutics , by Sales Channel
5. Rest of the World Liver Cancer Therapeutics
1. Rest of the World Liver Cancer Therapeutics , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Liver Cancer Therapeutics , by Product
3. Rest of the World Liver Cancer Therapeutics , by Type
4. Rest of the World Liver Cancer Therapeutics , by Gender
5. Rest of the World Liver Cancer Therapeutics , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 86
The Alkaptonuria Therapeutics Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...
The NCI Digital Therapeutics Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactur...
The CDDCI Digital Therapeutics Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...
The VDCI Digital Therapeutics Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...
The Cancer Treatment Support Services Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Laser Cancer Therapy Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/...
The Castrate Resistant Prostate Cancer Therapeutics Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitiv...
Market Overview
The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...
Market Overview
The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...
Market Overview
The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...